HIV, the virus that causes AIDS, has become one of the world's most devastating diseases since it was first recognized more than three decades ago.
Keep Reading →
August 23 - News
The Medicines Company (NASDAQ:MDCO) is a mid-cap value stock that jumped by 21% in the last 12 months, trading at a 52-week price range of $20.04-$37.40.
Keep Reading →
August 23 - News
In the eyes of many of your peers, hedge funds are perceived as useless, outdated financial tools of a forgotten age.
Keep Reading →
August 22 - News
If you've ever taken the time to really follow the biopharmaceutical sector, you know very well that failures are a dime a dozen, and success stories are few and far between.
Keep Reading →
August 19 - News
At least the Food and Drug Administration is polite.
Keep Reading →
August 19 - News
Last week, the Trust for America's Health and the Robert Wood Johnson Foundation released their annual report (link opens a PDF to a 116-page report) on obesity trends in the ...
Keep Reading →
August 19 - News
The long promise of insulin that diabetics can inhale appears to be moving closer to the market.
Keep Reading →
August 14 - News
Eli Lilly & Co. (NYSE:LLY) was in 35 hedge funds' portfolio at the end of March. LLY investors should be aware of a decrease in hedge fund interest recently.
Keep Reading →
August 13 - News
Pharmaceutical companies are always looking for competitive advantages.
Keep Reading →
August 13 - News
Mosquito bites sure suck, literally and figuratively. But more so if these are delivered by the insects’ female species, which cause viral infections. But forget malaria.
Keep Reading →
August 12 - News
With the full implementation of the individual portion of the Patient Protection and Affordable Care Act less than five months away, physicians and doctor's offices around the...
Keep Reading →
August 12 - News
In a companion article a few days ago, I predicted that MannKind Corporation (NASDAQ:MNKD)'s extended phase 3 program for its inhaled insulin, Afrezza, is likely to produce ...
Keep Reading →
August 12 - News
Over the past year, the battle over cancer treatments has heated up considerably. Big pharma companies such as Amgen, Inc. (NASDAQ:AMGN), Pfizer Inc.
Keep Reading →
August 7 - News
In America, 33.5% of adults over the age of 20 have high LDL (“bad”) cholesterol levels, according to the CDC.
Keep Reading →
August 7 - News
The National Headache Foundation (yes, there is such an organization) says that around 30 million Americans suffer from migraines.
Keep Reading →
August 6 - News
With the Federal Reserve set to start tapering asset purchases in September, it is time to start looking for stocks that offer some protection from the impending market volatility...
Keep Reading →
August 5 - News
Zoetis will release its quarterly report on Tuesday, and investors will get their first look at the company as a completely independent business entity.
Keep Reading →
August 5 - News
During the past decade, healthcare has been one of the most stable and consistent performers among all industries.
Keep Reading →
August 5 - News
Diabetes is one of the world's most dangerous and fastest-growing afflictions.
Keep Reading →
August 1 - News
It’s estimated that 30% to 40% of adults in the world experience some degree of insomnia every year. Most of these cases aren’t chronic and do not require medication.
Keep Reading →
August 1 - News
Merck & Co., Inc. (NYSE:MRK) might be one of big pharma's largest companies, but this health care leader has had a tough go recently.
Keep Reading →
July 31 - News
The good news was that the big pharmaceutical company beat earnings estimates. Merck & Co., Inc.
Keep Reading →
July 31 - News
So much for the stock market gains that dominated most of today's trading.
Keep Reading →
July 30 - News
This morning the Dow Jones Industrial Average (INDEXDJX:.DJI)'s two big drug companies and a number of smaller drug-related companies announced earnings.
Keep Reading →
July 30 - News
AstraZeneca plc (ADR) (NYSE:AZN) and Bristol Myers Squibb Co. (NYSE:BMY) announced last week that they are making another attempt at U.S.
Keep Reading →
July 30 - News
GlaxoSmithKline plc (ADR) (NYSE:GSK) has been accused of the violation of Chinese laws wherein the company’s key officials have used around 700 agencies and firms for increasing...
Keep Reading →
July 29 - News
The aging population as well as the higher number of people who will receive benefits under new healthcare laws should combine to produce rising profits for a variety of companies...
Keep Reading →
July 29 - News
After last week, when eight of the Dow Jones Industrial Average's 30 components reported earnings, this week may seem slow, with only four companies releasing their second-quarter...
Keep Reading →
July 29 - News
We often take sleep, the number of hours we get to sleep, or the quality of sleep we get, for granted.
Keep Reading →
July 29 - News
Eli Lilly & Co. (NYSE:LLY) will release its quarterly report tomorrow, and recent share-price declines show that investors are somewhat nervous about the company's prospects.
Keep Reading →
July 26 - News
For Eli Lilly & Co. (NYSE:LLY), history is repeating itself once again.
Keep Reading →
July 25 - News
Suppose we filled a jar with slips of paper with the names of biotech companies that have been around for at least 10 years and with a market cap of at $500 million or more written...
Keep Reading →
July 24 - News
Uncertainty creates opportunity for long-term investors, and there is a lot of uncertainty in the healthcare sector right now.
Keep Reading →
July 24 - News
By age 35, around two-thirds of all American men will have begun to experience androgenetic alopecia, more commonly known as male pattern baldness.
Keep Reading →
July 24 - News
Picking the best dividend stocks isn't just a matter of finding the highest-yielding picks.
Keep Reading →
July 23 - News
The recent rally in shares of Teva Pharmaceutical Industries Ltd (ADR) (NYSE:TEVA) may suggest investors are regaining some confidence in this pharmaceutical manufacturer.
Keep Reading →
July 23 - News
According to multiple reports , Harvard researchers Timothy Henrich and Daniel Kuritzkes have recently noted a surprising side-effect to cancer treatments performed on two separate...
Keep Reading →
July 22 - News
There's little denying that the technological, research, and medicinal aspects of patient care are improving at breakneck speed.
Keep Reading →
July 22 - News
What if I told you that there's a business risk out there that 90% of companies in the S&P Global 100 index perceive as legitimate, but that few are managing in any real fashion...
Keep Reading →
July 22 - News
The Food and Drug Administration cancelled an advisory meeting planned for Merck & Co., Inc. (NYSE:MRK)’s post-surgery drug sugammadex.
Keep Reading →
July 19 - News
The pharmaceutical sector is mainly about the pipeline of new products and patents.
Keep Reading →
July 19 - News
Most recently, executives working for the U.K.-based GlaxoSmithKline plc (ADR) (NYSE:GSK) in China have been accused of, and confessed to, serious corruption and tax-related ...
Keep Reading →
July 19 - News
Amid sluggish sales growth, the Pharmaceutical Industry giants are struggling with declining revenues and profits.
Keep Reading →
July 18 - News
Sustainability and a strong pipeline are the two tests that best evaluate a pharmaceutical company. Merck & Co., Inc. (NYSE:MRK) scores high on both counts.
Keep Reading →
July 18 - News
Johnson & Johnson (NYSE:JNJ) is scheduled to release its quarterly earnings report tomorrow, and as a huge health-care conglomerate with a strong presence in consumer health-care...
Keep Reading →
July 16 - News
With all of the factors we have to worry about in our everyday lives, it is somewhat a wonder that we're not only able to survive, but thrive, as a society.
Keep Reading →
July 15 - News
The Centers for Disease Control recently released a study showing that the introduction of human papillomavirus vaccines has significantly reduced infection rates among teenaged...
Keep Reading →
July 15 - News
Dividend stocks have gotten incredibly popular among investors as the search for income has led many to take on more risk in their portfolios in order to generate the cash flow...
Keep Reading →
July 15 - News
Dividend stocks outperform non-dividend-paying stocks over the long run.
Keep Reading →
July 14 - News
